These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9024176)

  • 1. Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma.
    De Lepeleire I; Reiss TF; Rochette F; Botto A; Zhang J; Kundu S; Decramer M
    Clin Pharmacol Ther; 1997 Jan; 61(1):83-92. PubMed ID: 9024176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
    Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
    Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval.
    Bronsky EA; Kemp JP; Zhang J; Guerreiro D; Reiss TF
    Clin Pharmacol Ther; 1997 Nov; 62(5):556-61. PubMed ID: 9390112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
    Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
    N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast.
    Pearlman DS; van Adelsberg J; Philip G; Tilles SA; Busse W; Hendeles L; Loeys T; Dass SB; Reiss TF
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):98-104. PubMed ID: 16892789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged effect of montelukast in asthmatic children with exercise-induced bronchoconstriction.
    Kim JH; Lee SY; Kim HB; Kim BS; Shim JY; Hong TJ; Hong SJ
    Pediatr Pulmonol; 2005 Feb; 39(2):162-6. PubMed ID: 15633203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against exercise-induced bronchoconstriction two hours after a single oral dose of montelukast.
    Philip G; Villarán C; Pearlman DS; Loeys T; Dass SB; Reiss TF
    J Asthma; 2007 Apr; 44(3):213-7. PubMed ID: 17454341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of exercise training and montelukast in children with mild asthma.
    Bonsignore MR; La Grutta S; Cibella F; Scichilone N; Cuttitta G; Interrante A; Marchese M; Veca M; Virzi' M; Bonanno A; Profita M; Morici G
    Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma.
    Rorke S; Jennison S; Jeffs JA; Sampson AP; Arshad H; Holgate ST
    Thorax; 2002 Apr; 57(4):323-7. PubMed ID: 11923550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise.
    Rundell KW; Spiering BA; Baumann JM; Evans TM
    Br J Sports Med; 2005 Apr; 39(4):232-6. PubMed ID: 15793094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.
    Reiss TF; Altman LC; Chervinsky P; Bewtra A; Stricker WE; Noonan GP; Kundu S; Zhang J
    J Allergy Clin Immunol; 1996 Sep; 98(3):528-34. PubMed ID: 8828530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.
    Manning PJ; Watson RM; Margolskee DJ; Williams VC; Schwartz JI; O'Byrne PM
    N Engl J Med; 1990 Dec; 323(25):1736-9. PubMed ID: 2174121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U; Dass SB
    Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I randomized, placebo-controlled, dose-exploration study of single-dose inhaled montelukast in patients with chronic asthma.
    Philip G; Pedinoff A; Vandormael K; Tymofyeyev Y; Smugar SS; Reiss TF; Korenblat PE
    J Asthma; 2010 Dec; 47(10):1078-84. PubMed ID: 20936994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor.
    Casas A; Gómez FP; Dahlén B; Roca J; Barberà JA; Dahlén SE; Rodríguez-Roisin R
    Eur Respir J; 2005 Sep; 26(3):442-8. PubMed ID: 16135725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of montelukast, a leukotriene antagonist, on improvement of exercise-induced bronchoconstriction].
    Sun TY; Guo YF; Xu XM; Zhang HS; Hou J; Ke HX; Li YM; Fang BM; Ming SH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):83-7. PubMed ID: 15854387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human.
    Kips JC; Joos GF; De Lepeleire I; Margolskee DJ; Buntinx A; Pauwels RA; Van der Straeten ME
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):617-21. PubMed ID: 1892302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-effect of montelukast on protection against exercise-induced bronchoconstriction.
    Peroni DG; Pescollderungg L; Sandri M; Chinellato I; Boner AL; Piacentini GL
    Respir Med; 2011 Dec; 105(12):1790-7. PubMed ID: 21865022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of fluticasone and montelukast on allergen-induced asthma.
    Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
    Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.